Claudia Waskow

Regeneration in Hematopoiesis

Previous and current research

Immune cells are descendants of bone marrow-resident hematopoietic stem cells (HSC) and are regenerated throughout life, thus, they have the unique capability to continuously regenerate but also to give rise to non-self renewing multipotent progenitor cells. Regeneration of HSC can be shown by serial transplantation into irradiated recipient mice. We recently developed a mouse strain, which can be easily reconstituted without previous conditioning (irradiation or treatment with cytotoxic drugs) and we therewith defined all parameters involved in successful HSC transplantation. We will now use this tool to study regulatory mechanisms involved in HSC maintenance.
Dendritic cells (DCs) are important regulators of immune responses. Depending on their state of activation they can either induce immunity or tolerance. We have shown that DCs are short-lived and that they are continuously replenished from blood-borne progenitors, which have a strikingly low residence time during their transition through peripheral blood. Differentiation into distinct cell lineages is currently understood as a gradual loss of developmental potential. Identification of several lineage-committed progenitor populations in the bone marrow or spleen supports this model. Lineage-restricted progenitors are identifiable by expression of distinct combinations of cell surface markers. We performed gene expression profiling of DC-committed progenitor cells and now aim at understanding the molecular mechanisms underlying DC-lineage differentiation on a candidate-based approach.

Furthermore we will assess growth factor receptor requirements for the development of DC in vivo. To this end we will combine growth factor receptor mutants involved in DC generation aiming at generating a mouse mutant devoid of DC.

Future prospects and goals

Understanding the principles of continuous regeneration and cell differentiation is a prerequisite to modulate hematopoiesis. The lab will be focused on the identification of cellular and molecular events regulating hematopoietic cell fate decisions with emphasis on DC development.

About

1999-2002: PhD, University of Basel (Basel Institute for Immunology, University Clinics Ulm), Switzerland 2002-2005: Postdoctoral fellow, University Clinics Ulm, Germany 2005-2007: Postdoctoral Associate, Rockefeller University, New York, USA Jan 2008: Group leader at the Center for Regenerative Therapies, TU Dresden, Germany

Selected publications

C. Waskow, K. Liu, G. Darrase-Jeze, P. Guermonprez, F. Ginhoux, M. Merad, T. Shengelia, K. Yao, M. Nussenzweig (2008) The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat. Immunol.: Vol 9 (6), 676-683.

K. Liu, C. Waskow, X. Liu, K. Yao, J. Hoh, M. Nussenzweig (2007) Origin of dendritic cells in peripheral lymphoid organs of mice. Nat. Immunol.: Vol 8 (6), 578-583.

C. Waskow, S. Bartels, S. Schlenner, C. Costa, H.-R. Rodewald (2007) Kit is essential for PMA-inflammation-induced mast-cell accumulation in the skin. Blood: Vol 109 (12), 5363-70.

M. Stumpf, C. Waskow, M. Krötschel, D. van Essen, P. Rodriguez, B. Guyot, R. G. Roeder, T. Borggrefe (2006) The Mediator Complex Functions as a Coactivator for GATA-1 in Erythropoiesis via Subunit Med1/TRAP220. Proc Natl Acad Sci U S A: Vol 103 (49), 18504-9.

G. Terszowski, C. Waskow, P. Conradt, H-R. Rodewald. (2005) Prospective isolation and global gene expression analysis of the colony-forming unit-erythrocyte (CFU-E). Blood: Vol. 105 (5), 1937-1945.

C. Waskow, G. Terszowski, C. Costa, M. Gassmann, H-R. Rodewald. (2004) Rescue of lethal c-Kit(W/W) mice by erythropoietin. Blood: Vol. 104 (6), 1688-1695.

C. Waskow, S. Paul, C. Haller, H. Kissel, P. Besmer, M. Gassmann, H.-R. Rodewald. (2002) A viable c-Kit-deficient (Vickid) mouse mutant reveals pivotal role for c-Kit in maintenance of adult lymphopoiesis. Immunity: Vol. 17, 277-288.

Home page